Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion

Lignende værker

• ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
  af: Mao Y, et al.
  Udgivet: (2017-07-01)
• ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
  af: Mao, Yanjiao, et al.
  Udgivet: (2017)
• Activated RET and ROS: two new driver mutations in lung adenocarcinoma
  af: Bos, Marc, et al.
  Udgivet: (2013)
• EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
  af: He, Mai, et al.
  Udgivet: (2011)
• Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma
  af: Murano, Chihiro, et al.
  Udgivet: (2019)